Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality
Authors:
- 13 April 2020
- journal article
- review article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 33 (1) , 62-72
Abstract
Background and objective: Various treatments exist for androgenetic alopecia (AGA); we determined the relative efficacies of non-surgical AGA monotherapies separately for men and women. Methods: Randomized controlled trials (RCTs) were systematically searched in PubMed, EMBASE, Scopus and clinicaltrials.gov. Separate networks were used for men and women; for each network, a Bayesian network meta-analysis (NMA) of mean change in hair count from baseline (in units of hairs per squared centimetre) was performed using a random effects model. Results: The networks for male and female AGA included 30 and 10 RCTs, respectively. We identified the following treatments for male AGA in decreasing rank of efficacy: platelet-rich plasma (PRP), low-level laser therapy (LLLT), 0.5mg dutasteride, 1mg finasteride, 5% minoxidil, 2% minoxidil, and bimatoprost. For female AGA the following were identified in decreasing rank of efficacy: LLLT, 5% minoxidil, and 2% minoxidil. The evidence quality of the highest ranked therapies, for male and female AGA, was judged to be low. Conclusions: While newer treatments like LLLT may be more efficacious than more traditional therapies like 5% minoxidil, the efficacy of the more recent treatment modalities needs to be further validated by future RCTs.Keywords
This publication has 55 references indexed in Scilit:
- Network meta-analysis-highly attractive but more methodological research is neededBMC Medicine, 2011
- Differential endothelial cell gene expression by African Americans versusCaucasian Americans: a possible contribution to health disparity in vascular disease and cancerBMC Medicine, 2011
- The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasterideJournal of the American Academy of Dermatology, 2006
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJournal of the American Academy of Dermatology, 2004
- Finasteride in the treatment of men with androgenetic alopeciaJournal of the American Academy of Dermatology, 1998
- The German Double‐Blind Placebo‐Controlled Evaluation of Topical Minoxidil Solution in the Treatment of Early Male Pattern BaldnessInternational Journal of Dermatology, 1988
- Topical 2% Minoxidil Solution in Male Pattern Alopecia. The Initial European ExperienceInternational Journal of Dermatology, 1988
- Comparable efficacy of 2% minoxidil gel and solution formulations in the treatment of male pattern alopeciaJournal of the American Academy of Dermatology, 1988
- Dose-response study of topical minoxidil in male pattern alopeciaJournal of the American Academy of Dermatology, 1987
- Dose-response study of topical minoxidil in male pattern baldnessJournal of the American Academy of Dermatology, 1986